SHAREHOLDERS’ NEWSLETTER VIVESCIA INDUSTRIES 2022-2023 Industrial biotechnologies It’s full steam ahead for ARD, our biotechnology and bio-based chemistry business. With the ongoing boom in industrial biotechnology and an abundant customer portfolio, the business continues to grow. ARD passed a new milestone in its development last year, by adding capacity to its BioDémo industrial demonstrator. This strengthens the unique position it has, supporting customers as they scale up from lab trials through to full-scale production, in a wide range of applications spanning 昀椀ne chemicals, the food industry and healthcare. Thanks to this €8 million investment, ARD can meet strong international demand in industrial biotechnology and help bring to market bio-sourced molecules, made with renewable carbon, in preparation for the post-oil era. From left to right: Olivier de Bohan, President of Cristal Union; Christoph Launch of Büren, President of VIVESCIA; Henri Prévost, Prefect of the Marne Department; Philippe Aubry, Managing director of ARD; Catherine BioDémo 2 Vautrin, President of the greater Reims region; Olivier Miaux, Managing director of VIVESCIA Industries; Anne-Sophie Romagny, Senator of the Marne Department; Xavier Albertini, Deputy of the Marne Department 18 19